Immunogenic compositions for Chlamydia trachomatis
    61.
    发明申请
    Immunogenic compositions for Chlamydia trachomatis 失效
    沙眼衣原体的免疫原性组合物

    公开(公告)号:US20110158977A1

    公开(公告)日:2011-06-30

    申请号:US11920230

    申请日:2006-05-12

    CPC分类号: C07K14/295 Y10T436/143333

    摘要: The present invention provides variant LcrE sequences and/or combinations of variant LcrE sequences across the Chlamydia trachomatis serovars. Such changes in LcrE genotypes across the Chlamydia trachomatis serovars are likely to correspond with changes in LcrE phenotypes, in particular, with changes in immunogenicity. The present invention also provides peptides surrounding or associated with the amino acid substitutions, in particular, peptides surrounding or associated with high frequency mutated amino acid positions or hypervariable regions, which are likely to be B and/or T cell epitopic regions capable of eliciting Chlamydia specific cell mediated immune responses. The variant LcrE sequences and/or combinations of the variant LcrE sequences and/or epitope regions associated with the variant LcrE sequences are useful as immunogens and/or in the preparation of immunogenic compositions for preventing and/or treating and/or, diagnosing Chlamydia infections.

    摘要翻译: 本发明提供了穿过沙眼衣原体血清型沙眼衣原体的变体LcrE序列和/或变体LcrE序列的组合。 沙眼衣原体血清型的LcrE基因型的这种变化可能与LcrE表型的变化相一致,特别是随着免疫原性的变化。 本发明还提供了与氨基酸取代相关的肽,特别是与高频突变的氨基酸位置或高变区相关的肽,其可能是能诱导衣原体的B和/或T细胞表位区 特异性细胞介导的免疫应答。 与变体LcrE序列相关的变体LcrE序列和/或变体LcrE序列和/或表位区域的变体的变体LcrE序列和/或组合可用作免疫原和/或用于预防和/或治疗和/或诊断衣原体感染的免疫原性组合物 。

    IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES
    63.
    发明申请
    IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES 有权
    有机磷组分的免疫组化

    公开(公告)号:US20100221278A1

    公开(公告)日:2010-09-02

    申请号:US12715912

    申请日:2010-03-02

    IPC分类号: A61K39/09 A61P31/04

    摘要: The invention includes a GAS antigen, GAS 40, which is particularly suitable for use either alone or in combinations with additional GAS antigens, such as GAS 117, GAS 130, GAS 277, GAS 236, GAS 40, GAS 389, GAS 504, GAS 509, GAS 366, GAS 159, GAS 217, GAS 309, GAS 372, GAS 039, GAS 042, GAS 058, GAS 290, GAS 511, GAS 533, GAS 527, GAS 294, GAS 253, GAS 529, GAS 045, GAS 095, GAS 193, GAS 137, GAS 084, GAS 384, GAS 202, and GAS 057.

    摘要翻译: 本发明包括GAS抗原GAS40,其特别适用于单独使用或与额外的GAS抗原如GAS 117,GAS 130,GAS 277,GAS 236,GAS 40,GAS 389,GAS 504,GAS 509,GAS 366,GAS 159,GAS 217,GAS 309,GAS 372,GAS 039,GAS 042,GAS 058,GAS 290,GAS 511,GAS 533,GAS 527,GAS 294,GAS 253,GAS 529,GAS 045, GAS 095,GAS 193,GAS 137,GAS 084,GAS 384,GAS 202和GAS 057。

    IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS AGALACTIAE
    64.
    发明申请
    IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS AGALACTIAE 审中-公开
    用于结核分枝杆菌的免疫组化

    公开(公告)号:US20100015168A1

    公开(公告)日:2010-01-21

    申请号:US12303999

    申请日:2007-06-11

    摘要: The invention relates to immunogenic polypeptides derived from epitopes in a Streptococcus agalactiae (“GBS”) protein GBS 80 and their use as prophylactic, diagnostic and therapeutic compositions. The invention also provides nucleic acids encoding the immunogenic polypeptides. Also provided are vectors useful for making such immunogenic polypeptides and host cells transformed with such vectors. In particular, the invention relates to a group immunogenic polypeptides derived from GBS 80. The compositions may include one or more of the immunogenic polypeptides either alone or with other antigenic components. For example, the immunogenic polypeptides may be combined with other GBS antigens to provide therapeutic compositions with broader range. In addition, the immunogenic polypeptides may also include flanking portions of the GBS 80 protein.

    摘要翻译: 本发明涉及源自无乳链球菌(GBS)蛋白GBS 80中的表位的免疫原性多肽及其作为预防,诊断和治疗组合物的用途。 本发明还提供编码免疫原性多肽的核酸。 还提供了可用于制备这种免疫原性多肽的载体和用这些载体转化的宿主细胞。 特别地,本发明涉及衍生自GBS80的组免疫原性多肽。组合物可以单独或与其它抗原成分一起包括一种或多种免疫原性多肽。 例如,免疫原性多肽可以与其他GBS抗原组合以提供更宽范围的治疗组合物。 此外,免疫原性多肽还可以包括GBS 80蛋白的侧翼部分。

    Hepatitis C receptor protein CD81
    65.
    发明申请
    Hepatitis C receptor protein CD81 审中-公开
    丙型肝炎受体蛋白CD81

    公开(公告)号:US20070087407A1

    公开(公告)日:2007-04-19

    申请号:US11495151

    申请日:2006-07-28

    IPC分类号: C12P21/06

    摘要: The present invention relates to the use of CD81 protein and polynucleic acid in the therapy and diagnosis of hepatitis C and pharmaceutical compositions, animal models and diagnostic kits for such purposes.

    摘要翻译: 本发明涉及CD81蛋白和多核酸在丙型肝炎的治疗和诊断中的应用以及用于此目的的药物组合物,动物模型和诊断试剂盒。

    Process for the production of D-&agr;-amino acids
    68.
    发明授权
    Process for the production of D-&agr;-amino acids 失效
    生产D-α-氨基酸的方法

    公开(公告)号:US06566105B1

    公开(公告)日:2003-05-20

    申请号:US08415658

    申请日:1995-04-03

    IPC分类号: C12P1304

    CPC分类号: C12N9/80 C12N9/86 C12P41/009

    摘要: A process is described for the production of D-&agr;-amino acids by the stereospecific conversion of racemic mixtures of 5-substituted hydantoins using a microorganism transformed with a plasmid which expresses an enzymatic system which converts the hydantoins into the corresponding D-&agr;-amino acids without the requirement for inducers. Also described is a plasmid containing genes encoding the enzymatic system, and a microorganism transformed with the plasmid.

    摘要翻译: 描述了通过使用表达用于将乙内酰脲转化为相应的D-α-氨基酸的酶系统转化的微生物转化的5-取代的乙内酰脲的外消旋混合物的立体有择转化来生产D-α-氨基酸的方法 酸不需要诱导剂。 还描述了含有编码酶系统的基因的质粒和用质粒转化的微生物。